Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention
Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention
About this item
Full title
Author / Creator
Hideo-Kajita, Alexandre , Rogers, Toby , Buchanan, Kyle , Iantorno, Micaela , Gajanana, Deepakraj , Ozaki, Yuichi , Dan, Kazuhiro , Kolm, Paul , Brathwaite, Echo , Beyene, Solomon , Melaku, Gebremedhin , Meirovich, Yael , Dheendsa, Aaphtaab , Garcia-Garcia, Hector M. , Torguson, Rebecca and Waksman, Ron
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Percutaneous coronary intervention (PCI) in patients with angiographic evidence of intracoronary thrombus is associated with in-hospital and 30-day adverse clinical outcomes. Cangrelor, a direct, rapid-onset acting intravenous P2Y12 receptor inhibitor, has been proved to be effective by reducing peri-PCI ischemic complications in subjects who under...
Alternative Titles
Full title
Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2197885355
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2197885355
Other Identifiers
ISSN
0002-9149
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2019.01.031
